Goncalo C. Vilhais-Neto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Goncalo C. Vilhais-Neto has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Olivier Pourquié
Department of Genetics, Harvard Medical School, Boston, MA, USA.
2 shared publications Andrew Peterson
Genentech, South San Francisco, CA, United States
1 shared publication- Anita Saraf
Stowers Institute for Medical Research
1 shared publication - Jean-Luc Plassat
IGBMC
1 shared publication Jean-Marie Garnier
Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC)
1 shared publicationJerry Workman
Stowers Institute for Medical Research, Kansas City, MO, United States
1 shared publication
Latest Publications
- Open Access
A new coactivator complex required for retinoic acid-dependent regulation of embryonic symmetry
Bilateral symmetry is a striking feature of the vertebrate body plan organization. Vertebral precursors, called somites, provide one of the best illustrations of embryonic symmetry. Maintenance of somitogenesis symmetry requires Retinoic acid (RA) and its coactivator Rere/Atrophin2. Here, using a proteomic approach we identify a protein complex, containing W dr5, H dac1, H dac2 and R ere (named WHHERE), which regulates RA signalling and controls embryonic symmetry. We demonstrate that Wdr5, Hdac1 and Hdac2 are required for RA signalling in vitro and in vivo . Mouse mutants for Wdr5 and Hdac1 exhibit asymmetrical somite formation characteristic of RA-deficiency. We also identify the Rere-binding histone methyltransferase Ehmt2/G9a, as a RA coactivator controlling somite symmetry. Upon RA treatment, WHHERE and Ehmt2 become enriched at RA target genes to promote RNA Polymerase II recruitment. Our work identifies a novel protein complex linking key epigenetic regulators acting in the molecular control of embryonic bilateral symmetry.
Open AccessA new coactivator complex required for retinoic acid-dependent regulation of embryonic symmetry
Bilateral symmetry is a striking feature of the vertebrate body plan organization. Vertebral precursors, called somites, provide one of the best illustrations of embryonic symmetry. Maintenance of somitogenesis symmetry requires Retinoic acid (RA) and its coactivator Rere/Atrophin2. Here, using a proteomic approach we identify a protein complex, containing W dr5, H dac1, H dac2 and R ere (named WHHERE), which regulates RA signalling and controls embryonic symmetry. We demonstrate that Wdr5, Hdac1 and Hdac2 are required for RA signalling in vitro and in vivo . Mouse mutants for Wdr5 and Hdac1 exhibit asymmetrical somite formation characteristic of RA-deficiency. We also identify the Rere-binding histone methyltransferase Ehmt2/G9a, as a RA coactivator controlling somite symmetry. Upon RA treatment, WHHERE and Ehmt2 become enriched at RA target genes to promote RNA Polymerase II recruitment. Our work identifies a novel protein complex linking key epigenetic regulators acting in the molecular control of embryonic bilateral symmetry.
- 31 August 2009
- Published by Elsevier in Mechanisms of Development
- Vol. 126, S203-S204
13-P031 Rere (Atrophin2) controls retinoic acid signaling and somite bilateral symmetry
- 31 August 2009
- Published by Elsevier in Mechanisms of Development
- Vol. 126, S203-S204
13-P031 Rere (Atrophin2) controls retinoic acid signaling and somite bilateral symmetry